SIGRID is a Swedish consumer health company developing gut-local technologies designed to address metabolic challenges associated with modern dietary patterns.
The company’s patented SiPore® technology works locally in the gastrointestinal tract by interacting with digestive enzymes involved in carbohydrate and fat digestion. By slowing the breakdown of nutrients during digestion, SiPore® supports steadier post-meal metabolic responses and improved metabolic stability over time.
SIGRID collaborates with clinicians, researchers, and health innovators to translate metabolic science into practical solutions that support weight management, glucose stability, and long-term metabolic health.
SIGRID was founded by Prof. Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden.